C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 84 filers reported holding C4 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $406,825 | -35.8% | 218,723 | -5.1% | 0.00% | – |
| Q2 2023 | $634,057 | -41.6% | 230,566 | -33.3% | 0.00% | – |
| Q1 2023 | $1,085,131 | -35.2% | 345,583 | +21.7% | 0.00% | – |
| Q4 2022 | $1,675,317 | -54.6% | 283,952 | -32.5% | 0.00% | -100.0% |
| Q3 2022 | $3,691,000 | +271.7% | 420,843 | +219.5% | 0.00% | – |
| Q2 2022 | $993,000 | -65.8% | 131,724 | +10.0% | 0.00% | -100.0% |
| Q1 2022 | $2,906,000 | -59.9% | 119,789 | -46.7% | 0.00% | 0.0% |
| Q4 2021 | $7,241,000 | -38.6% | 224,848 | -14.8% | 0.00% | -66.7% |
| Q3 2021 | $11,794,000 | +35.0% | 263,964 | +14.3% | 0.00% | +50.0% |
| Q2 2021 | $8,739,000 | +1990.7% | 230,963 | +1729.6% | 0.00% | – |
| Q4 2020 | $418,000 | – | 12,624 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |